Brian Jarrett Mcmahon
#122,107
Most Influential Person Now
Brian Jarrett Mcmahon's AcademicInfluence.com Rankings
Brian Jarrett Mcmahonmedical Degrees
Medical
#1883
World Rank
#2264
Historical Rank
Public Health
#255
World Rank
#264
Historical Rank
Epidemiology
#297
World Rank
#314
Historical Rank

Download Badge
Medical
Brian Jarrett Mcmahon's Degrees
- PhD Epidemiology University of California, Berkeley
- Masters Public Health University of California, Berkeley
Why Is Brian Jarrett Mcmahon Influential?
(Suggest an Edit or Addition)Brian Jarrett Mcmahon's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013 (2015) (5270)
- Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015 (2016) (4388)
- Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015 (2016) (4293)
- Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017 (2018) (3308)
- Chronic hepatitis B: Update 2009 (2009) (2738)
- The Global Burden of Cancer 2013. (2015) (2336)
- Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance (2018) (2204)
- Chronic hepatitis B (2001) (1618)
- Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 (2018) (1515)
- Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2016 (2018) (899)
- Acute hepatitis B virus infection: relation of age to the clinical expression of disease and subsequent development of the carrier state. (1985) (821)
- Chronic hepatitis B: Update of recommendations (2004) (538)
- Chronic hepatitis B. (2002) (524)
- Chronic hepatitis B (2001) (475)
- Negative Immune Regulator Tim-3 Is Overexpressed on T Cells in Hepatitis C Virus Infection and Its Blockade Rescues Dysfunctional CD4+ and CD8+ T Cells (2009) (459)
- Serologic and Clinical Outcomes of 1536 Alaska Natives Chronically Infected with Hepatitis B Virus (2001) (432)
- Antiviral therapy for chronic hepatitis B viral infection in adults: A systematic review and meta‐analysis (2016) (390)
- Screening for hepatocellular carcinoma in Alaska natives infected with chronic hepatitis B: A 16‐year population‐based study (2000) (345)
- Accelerating the elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission. (2019) (329)
- Tim-3 expression on PD-1+ HCV-specific human CTLs is associated with viral persistence, and its blockade restores hepatocyte-directed in vitro cytotoxicity. (2010) (320)
- Hepatitis B-related sequelae. Prospective study in 1400 hepatitis B surface antigen-positive Alaska native carriers. (1990) (310)
- The natural history of chronic hepatitis B virus infection (2009) (298)
- Chronic hepatitis B virus infection. (2014) (291)
- Safety and immunogenicity of hepatitis A vaccine in patients with chronic liver disease (1998) (261)
- Antiviral therapy in chronic hepatitis B viral infection during pregnancy: A systematic review and meta‐analysis (2016) (260)
- Present and future therapies of hepatitis B: From discovery to cure (2015) (259)
- Antibody Levels and Protection after Hepatitis B Vaccination: Results of a 15-Year Follow-up (2005) (249)
- The influence of hepatitis B virus genotype and subgenotype on the natural history of chronic hepatitis B (2009) (246)
- Clearance of hepatitis B e antigen in patients with chronic hepatitis B and genotypes A, B, C, D, and F. (2007) (245)
- Hepatitis B virus genotypes in Alaska Native people with hepatocellular carcinoma: preponderance of genotype F. (2007) (244)
- Antibody levels and protection after hepatitis B vaccine: results of a 22-year follow-up study and response to a booster dose. (2009) (241)
- Clearance of hepatitis B surface antigen and risk of hepatocellular carcinoma in a cohort chronically infected with hepatitis B virus (2010) (233)
- Prevalence of autoimmune liver disease in Alaska natives (2002) (230)
- Antibody Levels and Protection After Hepatitis B Vaccine: Results of a 30-Year Follow-up Study and Response to a Booster Dose. (2016) (212)
- Integrations of the hepatitis B virus (HBV) and human papillomavirus (HPV) into the human telomerase reverse transcriptase (hTERT) gene in liver and cervical cancers (2003) (212)
- Natural history of chronic hepatitis B. (2010) (208)
- Epidemiology of Hepatitis B Virus Infection and Impact of Vaccination on Disease. (2016) (204)
- Reply: Potential conflict of interest: Nothing to report. (2007) (203)
- The Relationship among Previous Antimicrobial Use, Antimicrobial Resistance, and Treatment Outcomes for Helicobacter pylori Infections (2003) (200)
- Epidemiology and natural history of hepatitis B. (2005) (190)
- The long-term serological course of asymptomatic hepatitis B virus carriers and the development of primary hepatocellular carcinoma. (1985) (189)
- Protection provided by hepatitis B vaccine in a Yupik Eskimo population--results of a 10-year study. (1997) (179)
- [AASLD Practice Guidelines. Chronic hepatitis B: update of therapeutic guidelines]. (2004) (176)
- Is chronic hepatitis B being undertreated in the United States? (2011) (167)
- Elimination of hepatocellular carcinoma and acute hepatitis B in children 25 years after a hepatitis B newborn and catch‐up immunization program (2011) (160)
- A program to control an outbreak of hepatitis A in Alaska by using an inactivated hepatitis A vaccine. (1996) (160)
- Hepatitis B immunity in children vaccinated with recombinant hepatitis B vaccine beginning at birth: a follow-up study at 15 years. (2007) (154)
- Evolution of Hepatitis C Virus Quasispecies in Hypervariable Region 1 and the Putative Interferon Sensitivity-Determining Region during Interferon Therapy and Natural Infection (1998) (152)
- Duration of immunogenicity and efficacy of hepatitis B vaccine in a Yupik Eskimo population. (1989) (151)
- Long-term efficacy of hepatitis B vaccine, booster policy, and impact of hepatitis B virus mutants. (2005) (149)
- Elimination of new chronic hepatitis B virus infections: results of the Alaska immunization program. (2000) (148)
- Spontaneous death of Echinococcus multilocularis: cases diagnosed serologically (by Em2 ELISA) and clinical significance. (1987) (142)
- Treatment of children with chronic hepatitis B virus infection in the United States: Patient selection and therapeutic options (2010) (134)
- Update on Prevention, Diagnosis, and Treatment of Chronic Hepatitis B: AASLD 2018 Hepatitis B Guidance (2018) (133)
- Frequency of adverse reactions to hepatitis B vaccine in 43,618 persons. (1992) (133)
- Duration of Hepatitis B Immunity in Low Risk Children Receiving Hepatitis B Vaccinations From Birth (2004) (123)
- Hepatitis B‐associated polyarteritis nodosa in alaskan eskimos: Clinical and epidemiologic features and long‐term follow‐up (1989) (121)
- Persistence of Antibody to Hepatitis B and Protection From Disease Among Alaska Natives Immunized at Birth (2005) (117)
- Parasiticidal effect of chemotherapy in alveolar hydatid disease: review of experience with mebendazole and albendazole in Alaskan Eskimos. (1992) (112)
- A COMPREHENSIVE PROGRAMME TO REDUCE THE INCIDENCE OF HEPATITIS B VIRUS INFECTION AND ITS SEQUELAE IN ALASKAN NATIVES (1987) (100)
- Response to hepatitis B vaccine of persons positive for antibody to hepatitis B core antigen. (1992) (98)
- Early detection of primary hepatocellular carcinoma. Screening for primary hepatocellular carcinoma among persons infected with hepatitis B virus. (1985) (94)
- Differences in Response to a Hepatitis B Vaccine Booster Dose Among Alaskan Children and Adolescents Vaccinated During Infancy (2005) (94)
- Low frequency of p53 mutations observed in a diverse collection of primary hepatocellular carcinomas. (1992) (91)
- Hepatitis B virus DNA in persons with isolated antibody to hepatitis B core antigen who subsequently received hepatitis B vaccine. (1998) (91)
- The relationship between previous fluoroquinolone use and levofloxacin resistance in Helicobacter pylori infection. (2007) (90)
- Classification of hepatitis B virus genotype B into 2 major types based on characterization of a novel subgenotype in Arctic indigenous populations. (2007) (81)
- Reactivation of Hepatitis B During Immunosuppressive Therapy: Potentially Fatal Yet Preventable (2012) (80)
- Immunogenicity of an inactivated hepatitis A vaccine in Alaska Native children and Native and non-Native adults. (1995) (79)
- Hepatitis B Vaccination, Screening, and Linkage to Care: Best Practice Advice From the American College of Physicians and the Centers for Disease Control and Prevention (2017) (77)
- Hepatitis B virus precore mutation and fulminant hepatitis in the United States. A polymerase chain reaction-based assay for the detection of specific mutation. (1994) (75)
- Treatment of chronic hepatitis B virus infection in resource‐constrained settings: expert panel consensus (2011) (73)
- Epidemiology and risk factors for hepatitis C in Alaska Natives (2004) (72)
- 10 Worldwide prevalence and prevention of hepatitis c (2000) (69)
- Corrections to AASLD guidelines on chronic hepatitis B (2007) (68)
- Antiviral therapy in management of chronic hepatitis B viral infection in children: A systematic review and meta‐analysis (2016) (68)
- High rate of spontaneous negativity for hepatitis C virus RNA after establishment of chronic infection in Alaska Natives. (2006) (64)
- Seroprevalence of hepatitis B viral markers in 52,000 Alaska Natives. (1993) (63)
- SEROLOGICAL MARKERS OF HEPATITIS B VIRUS AND ALPHA-FETOPROTEIN LEVELS PRECEDING PRIMARY HEPATOCELLULAR CARCINOMA IN ALASKAN ESKIMOS (1982) (62)
- Prevalence of hepatitis B in selected Alaskan Eskimo villages. (1983) (62)
- A research agenda for curing chronic hepatitis B virus infection (2018) (61)
- Natural history of chronic hepatitis B - clinical implications. (2008) (61)
- Alaska Sentinel Surveillance for Antimicrobial Resistance in Helicobacter pylori Isolates from Alaska Native Persons, 1999–2003 (2006) (59)
- Protection provided by hepatitis B vaccine in a Yupik Eskimo population. Seven-year results. (1991) (57)
- Characterization of Helicobacter pylori cagA and vacA Genotypes among Alaskans and Their Correlation with Clinical Disease (2011) (56)
- Persistence of antibody to hepatitis A virus 10 years after vaccination among children and adults. (2008) (56)
- Comparison of serologic tests for the diagnosis and follow-up of alveolar hydatid disease. (1987) (55)
- Diagnostic accuracy of a fibrosis serum panel (FIBROSpect II) compared with Knodell and Ishak liver biopsy scores in chronic hepatitis C patients (2006) (53)
- Hepatitis C virus dynamics during natural infection are associated with long-term histological outcome of chronic hepatitis C disease. (2007) (53)
- Consequences of continuous mebendazole therapy in alveolar hydatid disease--with a summary of a ten-year clinical trial. (1986) (52)
- A Longitudinal Hepatitis B Vaccine Cohort Demonstrates Long-lasting Hepatitis B Virus (HBV) Cellular Immunity Despite Loss of Antibody Against HBV Surface Antigen. (2016) (52)
- Incidence of hepatocellular carcinoma according to hepatitis B virus genotype in Alaska Native people (2016) (52)
- Evaluation of the response to a booster dose of hepatitis B vaccine in previously immunized healthcare workers. (2001) (51)
- The diagnosis and treatment of Helicobacter pylori infection in Arctic regions with a high prevalence of infection: Expert Commentary (2015) (50)
- The control of hepatitis B virus infection with vaccine in Yupik Eskimos. Demonstration of safety, immunogenicity, and efficacy under field conditions. (1985) (49)
- Comparison of different HCV viral load and genotyping assays. (2003) (47)
- Immunogenicity of an Inactivated Hepatitis A Vaccine in Infants and Young Children (2007) (47)
- Reinfection after successful eradication of Helicobacter pylori: a 2‐year prospective study in Alaska Natives (2006) (47)
- Adverse outcomes in Alaska natives who recovered from or have chronic hepatitis C infection. (2010) (46)
- Recommendations for Screening, Monitoring, and Referral of Pediatric Chronic Hepatitis B (2009) (46)
- Advancing the High Throughput Identification of Liver Fibrosis Protein Signatures Using Multiplexed Ion Mobility Spectrometry* (2014) (45)
- The natural history of chronic hepatitis B virus infection. (2004) (44)
- Hepatocellular Carcinoma Risk in Alaska Native Children and Young Adults with Hepatitis B Virus: Retrospective Cohort Analysis. (2016) (44)
- Albendazole therapy in alveolar hydatid disease: a report of favorable results in two patients after short-term therapy. (1987) (42)
- Prevalence and causes of elevated serum aminotransferase levels in a population-based cohort of persons with chronic hepatitis B virus infection. (2014) (42)
- Secular trends in hepatitis A virus infection among Alaska Natives. (1993) (42)
- Evaluation of seaFAST, a Rapid Fluorescent In Situ Hybridization Test, for Detection of Helicobacter pylori and Resistance to Clarithromycin in Paraffin-Embedded Biopsy Sections (2005) (41)
- Hepatitis D outbreak among children in a hepatitis B hyper‐endemic settlement in Greenland (2010) (41)
- Primary hepatocellular carcinoma in alaskan natives, 1969–1979 (1981) (39)
- EPIDEMIOLOGY OF HEPATITIS B IN TWO ALASKAN COMMUNITIES (1977) (38)
- Increases in levels of antibody to hepatitis B surface antigen in an immunized population. (1998) (38)
- Alaska Sentinel Surveillance Study of Helicobacter pylori Isolates from Alaska Native Persons from 2000 to 2008 (2011) (38)
- Clinical significance of elevated alpha‐fetoprotein in Alaskan Native patients with chronic hepatitis C (2007) (36)
- Infection With Hepatitis C Virus Genotype 3 Is an Independent Risk Factor for End‐Stage Liver Disease, Hepatocellular Carcinoma, and Liver‐Related Death (2017) (36)
- Chronic Liver Disease among Alaska-Native People, 2003–2004 (2009) (35)
- The effect of IM ketorolac tromethamine on bleeding time: a prospective, interventional, controlled study. (2003) (35)
- Rates and risk factors for hepatitis B reactivation in a cohort of persons in the inactive phase of chronic hepatitis B-Alaska, 2001-2010. (2013) (35)
- Incidence of diabetes mellitus in a population‐based cohort of persons with chronic hepatitis B virus infection (2013) (34)
- Clustering of hepatocellular carcinoma in Alaska Native families (1991) (33)
- Evaluation of angled bar racks and louvers for guiding silver phase American eels (2003) (33)
- Evaluation of Behavior and Survival of Fish Exposed to an Axial-Flow Hydrokinetic Turbine (2015) (33)
- Reinfection after successful eradication of Helicobacter pylori in three different populations in Alaska (2014) (32)
- Genetic Diversity of Near Genome-Wide Hepatitis C Virus Sequences during Chronic Infection: Evidence for Protein Structural Conservation Over Time (2011) (32)
- Impact of immunizations on the disease burden of American Indian and Alaska native children. (2009) (32)
- Genetic diversity of hepatitis B virus genotypes B6, D and F among circumpolar indigenous individuals (2013) (32)
- Hepatitis A vaccine: immunogenicity following administration of a delayed immunization schedule in infants, children and adults. (2003) (31)
- Selecting Appropriate Management Strategies for Chronic Hepatitis B: Who to Treat (2006) (31)
- Long-term immunogenicity of hepatitis A virus vaccine in Alaska 17 years after initial childhood series. (2013) (30)
- Immunogenicity of the 23-valent pneumococcal polysaccharide vaccine in Alaska Native chronic alcoholics compared with nonalcoholic Native and non-Native controls. (1993) (29)
- Risk of end‐stage liver disease, hepatocellular carcinoma, and liver‐related death by fibrosis stage in the hepatitis C Alaska Cohort (2017) (29)
- Duration of protection against hepatitis A for the current two-dose vaccine compared to a three-dose vaccine schedule in children. (2013) (28)
- ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE (2007) (27)
- WGO Guidance for the Care of Patients With COVID-19 and Liver Disease (2020) (27)
- Diagnostic accuracy of tests for Helicobacter pylori in an Alaska Native population. (2011) (27)
- Mortality caused by chronic liver disease among American Indians and Alaska Natives in the United States, 1999-2009. (2014) (26)
- Evolution of hepatocellular carcinoma associated with chronic hepatitis B virus infection in Alaskan Eskimos. (1988) (26)
- Viral hepatitis in the Arctic (2004) (26)
- Persistence of hepatitis A vaccine induced seropositivity in infants and young children by maternal antibody status: 10‐year follow‐up (2012) (26)
- Estimating the Date of Hepatitis C Virus Infection from Patient Interviews and Antibody Tests on Stored Sera (2004) (25)
- An Association Between Core Mutations in Hepatitis B Virus Genotype F1b and Hepatocellular Carcinoma in Alaskan Native People (2018) (25)
- Nested case–control study: hepatocellular carcinoma risk after hepatitis B surface antigen seroclearance (2016) (24)
- Immune responses of prematurely born infants to hepatitis B vaccination: results through three years of age. (1998) (24)
- Azathioprine metabolite measurements are not useful in following treatment of autoimmune hepatitis in Alaska Native and other non-Caucasian people. (2011) (24)
- Primary liver cancer in Alaskan natives 1980–1985 (1987) (24)
- Research priorities for the discovery of a cure for chronic hepatitis B: Report of a workshop (2017) (23)
- Chronic carriers of hepatitis B virus who clear hepatitis B surface antigen: Are they really “off the hook”? (1998) (23)
- p53 is not mutated in hepatocellular carcinomas from Alaska Natives. (1995) (23)
- Impact of a statewide childhood vaccine program in controlling hepatitis A virus infections in Alaska. (2010) (22)
- Impact of recurrent epidemics of hepatitis a virus infection on population immunity levels: Bristol Bay, Alaska. (2002) (22)
- Comparison of enzyme immunoassay with radioimmunoassay for the detection of antibody to hepatitis B core antigen as the only marker of hepatitis b infection in a population with a high prevalence of hepatitis B (1990) (22)
- Relationship between level of hepatitis B virus DNA and liver disease: a population-based study of hepatitis B e antigen-negative persons with hepatitis B. (2014) (22)
- Hepatitis B virions isolated with antibodies to the pre‐S1 domain reveal occult viremia by PCR in Alaska Native HBV carriers who have seroconverted (2000) (21)
- Vasculitis in Eskimos living in an area hyperendemic for hepatitis B. (1980) (20)
- Helicobacter pylori infection and markers of gastric cancer risk in Alaska Native persons: a retrospective case-control study. (2014) (20)
- Use of Current and New Endpoints in the Evaluation of Experimental Hepatitis B Therapeutics (2017) (20)
- Prevalence of hepatitis B virus infection in Tonga: identifying high risk groups for immunization with hepatitis B vaccine. (1986) (20)
- Dynamics of Helicobacter pylori-Specific Immunoglobulin G for 2 Years after Successful Eradication of Helicobacter pylori Infection in an American Indian and Alaska Native Population (2006) (19)
- Hepatitis B virus genotypes in Alaska Native people with hepatocellular carcinoma : Preponderance of genotype F. Commentary (2007) (18)
- A prospective evaluation of 200 upper endoscopies performed in Alaska Native persons (2007) (18)
- Antimicrobial resistance among Helicobacter pylori isolates in Alaska, 2000-2016. (2018) (18)
- Delayed development of antibody to hepatitis B surface antigen after symptomatic infection with hepatitis B virus (1981) (18)
- Treatment eligibility in Alaska Native and American Indian persons with hepatitis C virus infection (2012) (18)
- Chronic Hepatitis B in Pregnancy A Workshop Consensus Statement on Screening, Evaluation, and Management, Part 1 (2012) (17)
- HBV Genotype: A Significant Risk Factor in Determining Which Patients With Chronic HBV Infection Should Undergo Surveillance for HCC: The Hepatitis B Alaska Study (2021) (17)
- Chronic hepatitis B infection: a workshop consensus statement and algorithm. (2011) (17)
- Environmental Effects of Hydrokinetic Turbines on Fish: Desktop and Laboratory Flume Studies (2013) (17)
- Factors associated with the progression of fibrosis on liver biopsy in Alaska Native and American Indian persons with chronic hepatitis C. (2010) (16)
- Severe abdominal vasculitis with hepatitis B antigenemia. (1980) (16)
- Viral hepatitis in the Arctic. A review from a Circumpolar Workshop on Viral hepatitis, ICCH13. (2007) (16)
- Hepatitis C infection in Alaska Natives with persistently normal, persistently elevated or fluctuating alanine aminotransferase levels (2006) (16)
- Results of a general hepatitis C lookback program for persons who received blood transfusions in a neonatal intensive care unit between January 1975 and July 1992. (2007) (16)
- Hepatitis-Associated Liver Cancer: Gaps and Opportunities to Improve Care. (2016) (16)
- Participant observation of a major design decision in industry (1979) (16)
- Strategic use of lamivudine in the management of chronic hepatitis B. (2013) (15)
- Combating gastric cancer in Alaska Native people: An expert and community symposium: Alaska Native Gastric Cancer Symposium. (2019) (15)
- Persistence of antibody to Hepatitis A virus 20 years after receipt of Hepatitis A vaccine in Alaska (2017) (15)
- Genetic and functional heterogeneity of the hepatitis C virus p7 ion channel during natural chronic infection. (2012) (15)
- Hepatitis C virus envelope glycoprotein co-evolutionary dynamics during chronic hepatitis C. (2008) (15)
- Hepatitis A vaccine immune response 22 years after vaccination (2018) (15)
- Investigation of Putative Multisubtype Hepatitis C Virus Infections In Vivo by Heteroduplex Mobility Analysis of Core/Envelope Subgenomes (2008) (15)
- Hepatitis B Virus Antibody Levels 7 to 9 Years after Booster Vaccination in Alaska Native Persons (2014) (14)
- Response to hepatitis B vaccine in Alaska natives with chronic alcoholism compared with non-alcoholic control subjects. (1990) (14)
- Hepatitis B and hepatocellular carcinoma in Eskimo/Inuit population. (1998) (14)
- The Effect of Helicobacter pylori Infection on Iron Stores and Iron Deficiency in Urban Alaska Native Adults (2013) (12)
- Precise, biomimetic replication of the multiscale structure of intestinal basement membrane using chemical vapor deposition. (2013) (12)
- Persistence of seropositivity among persons vaccinated for hepatitis A during infancy by maternal antibody status: 15‐year follow‐up (2016) (11)
- Burden and prevention of viral hepatitis in the Arctic region, Copenhagen, Denmark, 22–23 March 2012 (2013) (11)
- Hepatitis B‐associated vasculitis in Alaska Natives: viral genotype, clinical and serologic outcome (2007) (11)
- Hepatitis B surface antigen (HBsAg): a 40-year-old hepatitis B virus seromarker gets new life. (2010) (11)
- Hepatitis A vaccination for post-exposure prophylaxis in persons aged 40 years and older. (2014) (11)
- Prevalence and correlates of hepatitis C virus-associated inflammatory arthritis in a population-based cohort. (2017) (10)
- Long-term immunogenicity of inactivated hepatitis A vaccine: Follow-up at 15 years (2010) (10)
- Internist diagnosis and management of chronic hepatitis B virus infection. (2012) (10)
- Cost-effectiveness analysis of hepatocellular carcinoma screening by combinations of ultrasound and alpha-fetoprotein among Alaska Native people, 1983-2012. (2016) (9)
- Evaluation of angled bar racks and louvers for guiding lake and shortnose sturgeon (2002) (9)
- Observed Changes in Natural Killer and T cell Phenotypes with Evaluation of Immune Outcome in a Longitudinal Cohort Following Sofosbuvir-Based Therapy for Chronic Hepatitis C Infection (2019) (8)
- Hepatocellular carcinoma not related to hepatitis B virus infection among Alaska natives. (1999) (8)
- Hepatocellular carcinoma in Alaska Eskimos: epidemiology, clinical features, and early detection. (1990) (8)
- Treatment of chronic hepatitis B virus infection in resource-constrained settings: expert panel consensus (vol 31, pg 755, 2011) (2012) (8)
- Steatosis and hepatitis C in an Alaska Native/American Indian population (2006) (8)
- Results of a hepatitis C general transfusion lookback program for patients who received blood products before July 1992 (2005) (8)
- Group A streptococcal meningitis in an infant: report of a case associated with a community outbreak due to M-type 4 organisms. (1979) (7)
- Protection and antibody levels 35 years after primary series with hepatitis B vaccine and response to a booster dose (2022) (7)
- Presence of cagPAI genes and characterization of vacA s, i and m regions in Helicobacter pylori isolated from Alaskans and their association with clinical pathologies. (2020) (7)
- Implementing evidenced-based practice guidelines for the management of chronic hepatitis B virus infection. (2008) (7)
- Cascade of Care for Alaska Native People with Chronic Hepatitis C Virus Infection: Statewide Program with High Linkage to Care. (2019) (7)
- Autoimmune hepatitis in the Alaska Native population: autoantibody profile and HLA associations (2014) (7)
- Photoinitiated chemical vapor deposition of cytocompatible poly(2-hydroxyethyl methacrylate) films. (2014) (7)
- No inflammation? No cancer! Clear HBV early and live happily (2010) (6)
- Epidemiology of hepatitis B in two Alaska communities. (1977) (6)
- H. pylori-associated pathologic findings among Alaska native patients (2018) (6)
- Neonatal Calcaneous Osteomyelitis Related to Contaminated Mineral Oil (1977) (6)
- Does Incorporating Change in APRI or FIB-4 Indices Over Time Improve the Accuracy of a Single Index for Identifying Liver Fibrosis in Persons With Chronic Hepatitis C Virus Infection? (2016) (6)
- Immunogenicity of the hepatitis A vaccine 20 years after infant immunization. (2020) (6)
- Risk-Based Prenatal Hepatitis C Testing Practices and Results, Alaska 2013-2016 (2019) (6)
- Meeting the WHO and US Goals to Eliminate Hepatitis B Infection by 2030: Opportunities and Challenges (2018) (5)
- Immunogenicity of a combined hepatitis B and Haemophilus influenzae type b conjugate vaccine in Alaska Native infants. (1998) (5)
- Racial/ethnic disparities in hepatocellular carcinoma incidence and mortality rates in the United States, 1992–2018 (2022) (5)
- A prospective study of hepatitis B virus serologic markers and liver enzymes. (1980) (5)
- Hepatitis A vaccine immune response 22 years after vaccination. (2018) (5)
- Safety and immunogenicity of a combined hepatitis B virus-Haemophilus influenzae type B vaccine formulation in healthy adults. (1993) (5)
- Results of interferon-based treatments in Alaska Native and American Indian population with chronic hepatitis C (2016) (4)
- Role of combination therapy in chronic hepatitis B (2009) (4)
- Detection of alpha-fetoprotein and hepatitis-B surface antigen in blood spotted on filter paper: use as a screen for hepatocellular carcinoma in Alaska Natives. (1996) (4)
- Editorial Commentary: Sliding Down the Cascade of Care for Chronic Hepatitis B Virus Infection. (2016) (4)
- Sepsis due to Streptococcus pneumoniae in a patient with alcoholism who received pneumococcal vaccine. (1999) (4)
- Hepatitis A vaccine immunogenicity 25 years after vaccination in Alaska (2020) (4)
- Hepatitis B virus replication and tuberculin reactivity: studies in Alaska. (1987) (4)
- The changing epidemiology and aetiology of hepatocellular carcinoma from 1969 through 2013 in Alaska Native people (2016) (4)
- Cost-effectiveness analysis of hepatocellular carcinoma screening by combinations of ultrasound and alpha-fetoprotein among Alaska Native people, 1983–2012 (2016) (4)
- Hepatitis C in pregnant American Indian and Alaska Native women; 2003-2015 (2019) (4)
- The relationship between previous antimicrobial use, antimicrobial resistance and treatment outcome among Alaskans treated for Helicobacter pylori infection (2019) (3)
- Predicting treatment eligibility for hepatitis B in low income regions: Can treatment scores without HBV DNA testing serve the purpose? (2018) (3)
- Risk Factors for Helicobacter pylori Resistance (2004) (3)
- Results of interferon-based treatments in Alaska Native and American Indian population with chronic hepatitis C. (2016) (3)
- The role of primary care physician assistants in managing chronic hepatitis B (2014) (2)
- Reply: HEPATOLOGY, Vol. XX, No. X, 2016 (2016) (2)
- Letter: hepatitis B surface seroclearance does reduce the risk of hepatocellular carcinoma ‐ authors' reply (2016) (2)
- Liver disease in the indigenous populations of the Arctic, sub- (2006) (2)
- Recent advances in managing hepatitis B (2010) (2)
- Response to Editorial (2018) (2)
- Laboratory Evaluation of Modified Ristroph Traveling Screens for Protecting Fish at Cooling Water Intakes (2006) (2)
- Two Key Components to Address Chronic Hepatitis B in Children: Detection and Prevention. (2015) (2)
- Reply (2018) (2)
- Nifedipine--induced hepatitis. (1986) (2)
- 577 A lookback program to notify persons who received blood products in a neonatal intensive care unit before July 1992 of their risk for hepatitis C virus (HCV) infection: results for those with managed care providers versus private sector providers (2003) (1)
- Combination of Pegylated Interferon and Tenofovir for Hepatitis B Treatment: Screening and Counseling of Patients are Warranted. (2016) (1)
- Screening for Hepatitis B (2013) (1)
- Immunization of newborns of HBsag‐ positive mothers: A successful first step in control of hepatitis B virus in Taiwan (1989) (1)
- Unnecessary Prehospital Spinal Immobilization (2005) (1)
- 937 A prospective study of abnormal serum aminotransferase levels in a population-based cohort of 1057 persons chronically infected with hepatitis B virus (2003) (1)
- Patterns of HBeAg and HBsAg clearance among a treatment‐naive Alaskan Cohort in a long‐term observational study (2020) (1)
- B型肝炎ウイルス(HBV)慢性感染者におけるB型肝炎表面抗原の陰性化と肝細胞癌のリスク (2010) (1)
- Hepatitis B virus elimination status and strategies in circumpolar countries, 2020 (2021) (1)
- What should we clinicians do for healthy, asymptomatic, hbsag‐positive carriers? (1993) (1)
- An ELISA test for diagnosis and screening of echinococcus multilocularis in a high-risk Inupiat Eskimo population. (1988) (1)
- Impact of Programs to Manage Alaska Native Patients with Chronic Hepatitis B and C in Urban and Remote Rural Areas using a Data Base Registry. (2014) (1)
- Hepatocellular carcinoma and hepatitis B virus: family matters. (2013) (1)
- Summary of available surveillance data on hepatitis C virus infection from eight Arctic countries, 2012 to 2014 (2018) (1)
- 202 Hepatitis B virus genotypes in Alaska natives with hepatocellular carcinoma: preponderance of genotype F (2003) (1)
- Workshop on hepatitis B in circumpolar countries. Summary of the hepatitis B workshop. (1988) (1)
- NEGATIVE IMMUNE REGULATOR TIM-3 IS OVEREXPRESSED ON INTRAHEPATIC AND PERIPHERAL T CELLS IN CHRONIC HCV INFECTION AND ITS BLOCKADE RESCUES DYSFUNCTIONAL CD4+AND CD8+T CELLS (2009) (1)
- Hepatitis B Vaccination, Screening, and Linkage to Care (2018) (1)
- blood culture yielded S. pneumoniae that was susceptible to both Sepsis Due to Streptococcus pneumoniae in a Patient with (1999) (0)
- Results of interferon-based treatments in Alaska Native and American Indian population with chronic hepatitis C (2016) (0)
- Faculty of 1000 evaluation for Integration of hepatitis B virus S gene impacts on hepatitis B surface antigen levels in patients with antiviral therapy. (2018) (0)
- Developing and implementing a program of grand rounds for internists that is free of commercial bias. (2003) (0)
- 390 Steatosis and hepatitis C in a native American population (2003) (0)
- 587 Retrospective study correlating the prometheus liver fibrosis panel with findings of fibrosis on percutaneous liver biopsy specimens in Alaska natives with hepatitis C (2003) (0)
- Interpreting hepatitis B surface antigen levels: useful clinical test or just another confusing assay? (2012) (0)
- Vaccination Status of Alaska Native Persons With Hepatitis A Virus Infection-Alaska, 1996-2018. (2020) (0)
- Faculty Opinions recommendation of Screening for hepatitis C virus infection in adults: a systematic review for the U.S. Preventive Services Task Force. (2013) (0)
- Faculty Opinions recommendation of Hepatitis C virus reactivation in patients receiving cancer treatment: A prospective observational study. (2018) (0)
- T1802 Genotyping of vacA and CagA from Helicobacter pylori Isolates in Alaska (2008) (0)
- CLINICAL—LIVER, PANCREAS, AND BILIARY TRACT Adverse Outcomes in Alaska Natives Who Recovered From or Have Chronic Hepatitis C Infection (2010) (0)
- Reply: (2007) (0)
- Faculty Opinions recommendation of A randomized controlled trial of an integrated alcohol reduction intervention in patients with hepatitis C infection. (2020) (0)
- Evaluation of fish behavioural barriers (1998) (0)
- during Interferon Therapy and Natural Infection Interferon Sensitivity-Determining Region Hypervariable Region 1 and the Putative Evolution of Hepatitis C Virus Quasispecies in (2013) (0)
- Faculty Opinions recommendation of Efficacy of maternal tenofovir disoproxil fumarate in interrupting mother-to-infant transmission of hepatitis B virus. (2015) (0)
- Faculty Opinions recommendation of Reducing risk for mother-to-infant transmission of hepatitis C virus: a systematic review for the U.S. Preventive Services Task Force. (2013) (0)
- The Alaska Native/American Indian experience of hepatitis C treatment with sofosbuvir-based direct-acting antivirals (2021) (0)
- 201 Hepatitis B associated vasculitis in Alaska natives: Viral genotype, clinical and serologic outcome and incidence of new cases over time after initiation of hepatitis B vaccination program (2003) (0)
- High frequency of clarithromycin and metronidazole resistance in Helicobacter pylori isolates from Alaska natives (2003) (0)
- Viral Hepatitis: Free Papers (2014) (0)
- Reply: (2007) (0)
- T1021 Liver Biopsy Results and Risk Factors for Advanced Liver Disease in a Large Population-Based Cohort of HCV Carriers Undergoing Liver Biopsy (2008) (0)
- Reply: (2007) (0)
- Update on Diagnosis and Treatment within the Four Clinical Phases of Chronic Hepatitis B Infection (2011) (0)
- Table of contents (2016) (0)
- Comparing the Cost-Effectiveness of Two Approaches to Hepatocellular Carcinoma (HCC) Surveillance in Persons with Chronic Hepatitis B (CHB) Virus Infection. (2014) (0)
- Reply (2003) (0)
- Long-Term Protection and Antibody Levels 35 Years after Primary Immunization Series with Hepatitis B Vaccine and Response to a Booster Dose in Those Persons Who Lost Antibody (2021) (0)
- Letter: hepatocellular carcinoma risk after hepatitis B surface antigen seroclearance – authors’ reply (2017) (0)
- 23rd Annual Conference of APASL March 12–15, 2014, Brisbane, Australia (2014) (0)
- Faculty Opinions recommendation of Combination of Entecavir/Peginterferon Alfa-2a in Children With Hepatitis B e Antigen-Positive Immune Tolerant Chronic Hepatitis B Virus Infection. (2019) (0)
- Hepatitis B Virus Core Variants, Liver Fibrosis, and Hepatocellular Carcinoma (2019) (0)
- Preventing Perinatal Transmission of Hepatitis B Necessitates Consideration of Antiviral Treatment in Pregnancy (2018) (0)
- Mortality among Alaska Native Adults with Confirmed Hepatitis C Virus Infection Compared with the General Population in Alaska, 1995–2016 (2022) (0)
- Reply: (2002) (0)
- An Evidence-based Practical Guide to Vaccination for Hepatitis B Virus (2022) (0)
- Multi-scale Replication of Small Intestine Basement Membrane via Chemical Vapor Deposition (2010) (0)
- Reply (2016) (0)
- MortalityCausedbyChronicLiverDiseaseAmong AmericanIndiansandAlaskaNativesintheUnitedStates, 1999-2009 (2014) (0)
- Preliminary assessment of hepatitis B-specific cellular immunity amongst a longitudinal vaccine cohort demonstrates evidence of natural exposure. (VAC11P.1110) (2015) (0)
- European Helicobacter Study Group: Abstracts of the XXIVth International Workshop on Helicobacter and related bacteria in chronic digestive inflammation and gastric cancer (2011) (0)
- 402 Clinical and demographic features of hepatitis C-infected Alaska natives with persistently normal, persistantly elevated or fluxuating alanine transaminase levels (2003) (0)
- Poster Sessions (2013) (0)
- 88 Reported hepatitis c infection in american indian and alaska native mothers, 2011–2015 (2018) (0)
- Helicobacter pylori Antimicrobial Resistance and Treatment for Alaska Native People (2011) (0)
- Reply (2021) (0)
- Cost-effectiveness analysis of hepatocellular carcinoma screening by combinations of ultrasound and alpha-fetoprotein among Alaska Native people, 1983-2012. (2016) (0)
- Faculty Opinions recommendation of Long-Term Risk of Hepatocellular Carcinoma in HCV Patients Treated With Direct Acting Antiviral Agents. (2020) (0)
- Population-Based Longitudinal Study of Hepatitis B “e” Antigen Negative persons with Chronic Hepatitis B: Level of HBV DNA and Liver Disease (2015) (0)
- Australian tax planning, with precedents (1961) (0)
- Reply (2016) (0)
- Evaluation of Modular and Scalable Downstream Passage Systems for Silver American Eels (2021) (0)
- Prevention of viral hepatitis in circumpolar populations. (1991) (0)
- 544 INTRA-HOUSEHOLD TRANSMISSION HEPATITIS B VIRUS (HBV) INFECTION (1985) (0)
- Abstract: The evaluation of production potentials of demethanation wells utilizing “hot-wire” gas detection methods (1982) (0)
- Seasonal Variations in Sensitivity of Microorganisms to Antibiotics (1955) (0)
- Observed increases in CD4:CD8 and TIGIT expression during sofosbuvir-based therapy in a longitudinal hepatitis C cohort (2018) (0)
- Treatment eligibility in Alaska Native and American Indian persons with hepatitis C virus infection. (2012) (0)
- Treatment eligibility in Alaska Native and American Indian persons with hepatitis C virus infection. (2012) (0)
- Faculty Opinions recommendation of Hepatitis C virus therapy is associated with lower health care costs not only in noncirrhotic patients but also in patients with end-stage liver disease. (2013) (0)
- Faculty Opinions recommendation of Comparative effectiveness of antiviral treatment for hepatitis C virus infection in adults: a systematic review. (2013) (0)
- Photoinitiated Chemical Vapor Deposition of Hydrogels for Use as Cell Culture Substrates (2010) (0)
- Use of Angiotensin-Converting Enzyme Inhibitors in Heart Failure and Renal Insufficiency (2004) (0)
This paper list is powered by the following services: